At least a third of U.S. adults with ADHD do not access recommended treatments (medication or cognitive behavioral therapy [CBT]), and those receiving treatment face barriers (e.g., inconsistent availability of medication). We investigated systemic inequities in CBT access for adults with ADHD versus psychiatric diagnoses with similar prevalence.
Method:
We accessed and extracted publicly available listings from the Psychology Interjurisdictional Compact (PSYPACT) provider directory (N= 12,898) in April 2025.
Results:
Only 26.4% of PSYPACT providers explicitly offer any services for adult ADHD. They were nearly three times more likely to treat adult depression (69.2%) and anxiety (74.0%). CBT for adult ADHD was offered by just 21.3% of providers.
Conclusion:
U.S. psychologists are chief CBT providers for adult mental disorders; however, they systemically underserve adults with ADHD. Contributors to this inequity must be identified to advance adult ADHD care, as untreated ADHD is a costly public health burden.
DanielsonM. L.BohmM. K.NewsomeK.ClaussenA. H.KaminskiJ. W.GrosseS. G.SiwakotiL.ArifkhanovaA.BitskoR. H.RobinsonL. R. (2023). Trends in prescription stimulant fills among commercially insured children and adults — United States, 2016–2021. MMWR Morbidity and Mortality Weekly Report, 72(13), 327–332.
GinappC. M.Macdonald-GagnonG.AngaritaG. A.BoldK. W.PotenzaM. N. (2022). The lived experiences of adults with attention-deficit/hyperactivity disorder: A rapid review of qualitative evidence. Frontiers in Psychiatry, 13, Article 949321.
5.
KarasavvaV.MillerC.GrovesN.MontielA.CanuW.MikamiA. (2025). A double-edged hashtag: Evaluation of #ADHD-related TikTok content and its associations with perceptions of ADHD. PLoS ONE, 20(3), e0319335.
6.
LandisJ. R.KochG. G. (1977). An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics, 33, 363–374.
7.
LiY.ZhangL. (2024). Efficacy of cognitive behavioral therapy combined with pharmacotherapy versus pharmacotherapy alone in adult ADHD: A systematic review and meta-analysis. Journal of Attention Disorders, 28(3), 279–292.
8.
MathesonL.AshersonP.WongI. C. K.HodgkinsP.SetyawanJ.SasaneR.CliffordS. (2013). Adult ADHD patient experiences of impairment, service provision and clinical management in England: A qualitative study. BMC Health Services Research, 13(1), 184.
9.
MayT.BirchE.ChavesK.CranswickN.CulnaneE.DelaneyJ.DerrickM.EapenV.EdlingtonC.EfronD.EwaisT.GarnerI.GathercoleM.JagadheesanK.JobsonL.KramerJ.MackM.MissoM.Murrup-StewartC., . . . BellgroveM. (2023). The Australian evidence-based clinical practice guideline for attention deficit hyperactivity disorder. Australian & New Zealand Journal of Psychiatry, 57(8), 1101–1116.
10.
National Institute for Health and Care Excellence. (2019). Attention deficit hyperactivity disorder: Diagnosis and management (NICE guideline 87).
11.
NewcombeR. G. (1998). Improved confidence intervals for the difference between binomial proportions based on paired data. Statistics in Medicine, 17(22), 2635–2650.
12.
NorrisT.Adjaye-GbewonyoD.Bottoms-McClainL. (2024). Early release of selected estimates based on data grom the 2024 National Health Interview Survey. National Center for Health Statistics.
13.
OstinelliE. G.SchulzeM.ZanganiC.FarhatL. C.TomlinsonA.Del GiovaneC.ChamberlainS. R.PhilipsenA.YoungS.CowenP. J.BilbowA.CiprianiA.CorteseS. (2025). Comparative efficacy and acceptability of pharmacological, psychological, and neurostimulatory interventions for ADHD in adults: A systematic review and component network meta-analysis. The Lancet Psychiatry, 12(1), 32–43.
14.
SammonsM. T.ElchertD. M.MartinJ. N. (2021). Mental health service provision during COVID-19: Results of the third survey of licensed psychologists. Journal of Health Service Psychology, 47(3), 119–127.
15.
SibleyM. H.BickmanL.AtkinsD.TananaM.CoxeS. J.OrtizM.MartinP.KingJ.MonroyJ. M.PonceT.ChengJ.PaceB.ZhaoX.ChawlaV.PageT. (2023). Developing an implementation model for ADHD intervention in community clinics: Leveraging artificial intelligence and digital technology. Cognitive and Behavioral Practice, 31(4), 482–497.
16.
SibleyM. H.FaraoneS. V.NiggJ. T.SurmanC. B. (2023). Sudden increases in US stimulant prescribing: Alarming or not?Journal of Attention Disorders, 27(6), 571–574.
17.
SibleyM. H.GrahamE.HolbrookJ.DvorskyM. R.YeguezC. E.RosierT.CoghillD.PageT.F.FoucheR.DemuthJ. (2026). Demographic, service delivery, and practice trends in ADHD coaching in the U.S. JAMA Network Open.
18.
StaleyB. S.RobinsonL. R.ClaussenA. H.KatzS. M.DanielsonM. L.SummersA. D.FarrS. L.BlumbergS. J.TinkerS. C. (2024). Attention-deficit/hyperactivity disorder diagnosis, treatment, and telehealth use in adults—National center for health statistics rapid surveys system, United States, October–November2023. MMWR Morbidity and Mortality Weekly Report, 73, 890–895.
ValentineA. Z.HallS. S.YoungE.BrownB. J.GroomM. J.HollisC.HallC. L. (2021). Implementation of telehealth services to assess, monitor, and treat neurodevelopmental disorders: Systematic review. Journal of Medical Internet Research, 23(1), e22619.
21.
WilliamS.HorrocksM.RichmondJ.HallC. L.FrenchB. (2024). Experience of CBT in adults with ADHD: A mixed methods study. Frontiers in Psychiatry, 15, Article 1341624.
22.
YoungS.AshersonP.LloydT.AbsoudM.ArifM.ColleyW. A.CorteseS.CubbinS.DoyleN.MoruaS. D.Ferreira-LayP.GudjonssonG.IvensV.JarvisC.LewisA.MasonP.Newlove-DelgadoT.PittsM.ReadH., . . . SkirrowC. (2021). Failure of healthcare provision for attention-deficit/hyperactivity disorder in the United Kingdom: A consensus statement. Frontiers in Psychiatry, 12, Article 649399.
